Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults Academic Article Article uri icon

Overview

MeSH Major

  • Biometry
  • Decision Support Techniques
  • Forecasting
  • Models, Theoretical

abstract

  • Changes in cholesterol or quality of life associated with antiretroviral therapy do not justify limiting access to early HIV treatment. The effect of fat redistribution symptoms on quality of life will determine the optimal choice of early vs deferred therapy for an individual patient.

publication date

  • November 25, 2002

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1001/archinte.162.21.2478

PubMed ID

  • 12437408

Additional Document Info

start page

  • 2478

end page

  • 86

volume

  • 162

number

  • 21